Episodes

Thursday Apr 01, 2021
E74: Vasculitis Guidelines Episode 1 - Joyce Kullman
Thursday Apr 01, 2021
Thursday Apr 01, 2021
Welcome to the first episode of the Vasculitis Guidelines Podcast! In Episode 1, I interview Joyce Kullman, Executive Director of the Vasculitis Foundation, about collaborating with the ACR in updating these guidelines, and how patients with vasculitis will ultimately benefit from them. We discuss the complex process of updating these critical guidelines involve years of input from researchers, physicians, and patient themselves.

Wednesday Mar 31, 2021
E73: Introducing the Vasculitis Guidelines Podcast
Wednesday Mar 31, 2021
Wednesday Mar 31, 2021
Quick update on a new series!

Thursday Feb 25, 2021
E72: Avacopan for ANCA Vasculitis
Thursday Feb 25, 2021
Thursday Feb 25, 2021
Steroid free remission! Or is it? This week I discuss a really exciting trial in ANCA vasculitis.

Wednesday Jan 27, 2021
E71: MTX Discontinuation Post... Influenza Vaccination
Wednesday Jan 27, 2021
Wednesday Jan 27, 2021
I stole some time to tackle a pressing issue for rheumatologists - to hold or not to hold immunosuppression in patients who are receiving a COVID19 vaccination. We obviously don't have any data on this, but I have always loved this study on influenza vaccination. PDFs at ebrheum.com/twts and follow me on twitter @ebrheum!

Thursday Nov 19, 2020
E70: Rheum4Debate - HCQ Levels Should Be Monitored in Patients with SLE
Thursday Nov 19, 2020
Thursday Nov 19, 2020
We have a great show for you this week! Anisha Dua will be moderating a debate
between myself and Max Konig on this motion: "Hydroxychloroquine levels should be monitored in patients with SLE." I learned a ton and thoroughly enjoyed it. Be sure to vote on the post-debate twitter poll to decide the winner!

Thursday Oct 29, 2020
E69: Publication Trends in SRMAs and RCTs
Thursday Oct 29, 2020
Thursday Oct 29, 2020
This week I cover another of my meta-research projects, this one on systematic review and meta analysis (SRMA) growth as compared to randomized clinical trial (RCT) growth. Short and to the point - hope you enjoy! I highly recommend checking out the associated graphs - just take a quick peek at some point while listening. Find them on my twitter handle @ebrheum

Thursday Oct 15, 2020
E68: SELECT-CHOICE Upadacitinib vs Abatacept in RA
Thursday Oct 15, 2020
Thursday Oct 15, 2020
Active comparator trial! Always my favorite. Lots of fun topics in this one, including noninferiority trials, crafty endpoints, and PROs. Check it out and let me know what you think! @ebrheum

Thursday Oct 01, 2020
E67: Belimumab in Lupus Nephritis (BLISS-LN)
Thursday Oct 01, 2020
Thursday Oct 01, 2020
Another day, another lupus trial, another round of endpoint shenanigans. Why does that matter? How big is the benefit from belimumab in SLE nephritis? Will this save lives and prevent ESRD / RRT? I try to tackle these issues this week and (hopefully) avoid getting myself in trouble. Hope you enjoy the episode! Let me know what you think @ebrheum on twitter!

Thursday Sep 10, 2020
E66: MRI to Diagnose PMR
Thursday Sep 10, 2020
Thursday Sep 10, 2020
Great paper to discuss this week - one that may be too good to believe? I highly recommend checking out the pdf first (ebrheum.com/twts) - their graphics are wonderful and do a great job of conveying their message. Also, check out the "2-5-10" rule that I referenced! This is required reading for anyone who rotates with me - easily one of the most useful EBM papers I have ever read.

Wednesday Sep 02, 2020
E65: Anifrolumab in SLE - A Reply
Wednesday Sep 02, 2020
Wednesday Sep 02, 2020
Quick podcast this week that expands on issues I discuss in Episode 55. Go back and listen to that one first if you have time! I think this is an important issue and it's one I'd like to highlight. Let me know what you think @ebrheum and please share with friends!